These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38047925)

  • 1. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population.
    Montgomery SN; Syder N; Barajas G; Elbuluk N
    Arch Dermatol Res; 2023 Dec; 316(1):14. PubMed ID: 38047925
    [No Abstract]   [Full Text] [Related]  

  • 2. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 3. Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study.
    Savaş Erdoğan S; Falay Gür T; Doğan B
    J Cosmet Dermatol; 2021 Jul; 20(7):2232-2239. PubMed ID: 33089618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the psychological comorbidity in vitiligo: systematically casting the net wide.
    Thomson J
    Br J Dermatol; 2018 Apr; 178(4):826. PubMed ID: 29668098
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo is associated with new-onset osteoporosis: a retrospective cohort study.
    Cohen NT; Silverberg NB; Kridin K
    Arch Dermatol Res; 2024 Mar; 316(3):94. PubMed ID: 38427136
    [No Abstract]   [Full Text] [Related]  

  • 6. Comorbid diseases of vitiligo: A 10-year cross-sectional retrospective study of an urban US population.
    Hadi A; Wang JF; Uppal P; Penn LA; Elbuluk N
    J Am Acad Dermatol; 2020 Mar; 82(3):628-633. PubMed ID: 31325552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo on YouTube: A cross-sectional analysis.
    Carrington AE; Kitts S; Kleinwaks E; Luu J; Nguyen M; Park JH
    J Am Acad Dermatol; 2022 Jan; 86(1):199-201. PubMed ID: 33508386
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of camouflage in vitiligo: A cross-sectional survey.
    Poondru S; Kundu RV
    J Cosmet Dermatol; 2023 Dec; 22(12):3524-3526. PubMed ID: 37352455
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification and comparison of psychiatric distress in African patients with albinism and vitiligo: a 5-year prospective study.
    Ajose FO; Parker RA; Merrall EL; Adewuya AO; Zachariah MP
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):925-32. PubMed ID: 23875952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychosocial impacts of vitiligo, psoriasis, and alopecia areata on pediatric patients.
    Cruz S; Lei DK; Carr H; Rosenblatt A
    Dermatol Online J; 2023 Apr; 29(2):. PubMed ID: 37220281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo in underrepresented communities: An All of Us database analysis.
    Ahmed F; Moseley I; Ragi SD; Ouellette S; Rao B
    J Am Acad Dermatol; 2023 Apr; 88(4):945-948. PubMed ID: 36414097
    [No Abstract]   [Full Text] [Related]  

  • 12. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study.
    Lee YB; Kim S; Kim HS
    J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730
    [No Abstract]   [Full Text] [Related]  

  • 13. Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study.
    Salman A; Kurt E; Topcuoglu V; Demircay Z
    Am J Clin Dermatol; 2016 Jun; 17(3):305-11. PubMed ID: 26818062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based study.
    Kridin K; Lyakhovitsky K; Tzur-Bitan D; Onn E; Lyakhovitsky A; Zoller L; Cohen AD
    Australas J Dermatol; 2023 Feb; 64(1):e65-e71. PubMed ID: 36326157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy.
    Mansour MR; Abushukur Y; Rehman RA; Shah C; Mehregan D
    J Am Acad Dermatol; 2022 Dec; 87(6):1445-1448. PubMed ID: 35995610
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort.
    Pandya AG
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2159-2160. PubMed ID: 37877764
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of association between vitiligo and major adverse cardiovascular events: A population-based cohort study.
    Wu PC; Ma SH; Wu CY; Pan TY; Chang YT; Wu CY
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e773-e775. PubMed ID: 36734285
    [No Abstract]   [Full Text] [Related]  

  • 18. Demographics of Vitiligo in the DataDerm Database.
    Cunningham KN; Alsukait S; Learned C; Deverapalli S; Aninos A; Rosmarin D
    J Cutan Med Surg; 2023; 27(5):529-530. PubMed ID: 37522738
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitiligo and systemic lupus erythematosus: A population-based study investigating the epidemiological association.
    Kridin K; Abou Amara Y; Barhoum M; Cohen AD
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2262-2263. PubMed ID: 37326169
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of diversity in vitiligo clinical trials: a cross-sectional analysis.
    Hernandez LE; Verling S; Nouri K
    Arch Dermatol Res; 2023 Nov; 315(9):2735-2736. PubMed ID: 37486414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.